New tinnitus drugs

New tinnitus drugs often disappoint

Of all the new tinnitus drugs that are brought to market after extensive testing and early initial promise, all have so far have failed to cure the tinnitus ear problem. As just one example, one of the new tinnitus drugs is lidocaine, which has been shown to temporarily eliminate ear noise, but must be given intravenously and in doses so high that serious side effects were reported too often. In addition to the extreme side effects (migraine headaches, loss of bladder and bowel control, convulsions, unconsciousness, respiratory depression, cardiovascular collapse, cardiac arrest, and many less serious problems), and perhaps worst of all, lidocaine was shown often to exacerbate the very ear noise it was supposed to eliminate in some subjects. Other possible drug remedies for tinnitus from the lidocaine family, such as mexiletine, tocainide, and flecainide, have been shown to result in even more serious and adverse side effects in approximately 70% of all research participants, and this has often caused an unusually high dropout rate of approximately 50% of research participants.

In another area of medical research, that was initially very promising but has been recently disappointing, involves the use of antidepressants as a potential tinnitus treatment, but as of yet the results are at best inconclusive. Hopes are high, however, since there is a similar neurological phenomena at play between tinnitus and depression as well as special similarities to pain syndromes, it was hoped that treatment using tricyclic antidepressants would be beneficial for tinnitus also. Because of the complexity of the central nervous system, and the multifactoral causes of tinnitus, depression medication has not proven to perform beneficially for tinnitus to the original high expectations it was given.

Campral tested with other remedies for tinnitus

Campral, a new drug originally developed to assist alcoholics stay dry during their recovery, was used in a moderate sized fifty patient study in Brazil. As one of many new tinnitus drugs being tested on an on-going basis, Campral testing results were slightly to moderately positive, yet upon more detailed review some research weaknesses have been found in the manner in which the data was collected for the study. Additional studies, conducted by both independent and diverse sources, must be done to decide if Campral can eventually be added to the small list of the potential remedies for tinnitus.

Simply because of the frequent inconclusive findings in all of these studies, many field clinicians have turned recently to alternative methods to deal with constant ear noise. For additional information about the Alternative Medicine therapy plans TTI has to offer for the treatment of tinnitus, email or questions to info@tinnitus-treatment-institute.com or call 1-877-878-8188 to speak with a knowledgeable and friendly expert ready to discuss your tinnitus situation with you today.